A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : mCRPC

Search Conditions:
Search Keyword : mCRPC
Search Method : Exact match.
Research Area:

Abbreviation: mCRPC
Appearance Frequency: 1308 time(s)
Long forms: 12

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
metastatic castration-resistant prostate cancer
(1229 times)
(568 times)
OS (304 times)
PSA (274 times)
PFS (149 times)
0 [AR-V7 Androgen Receptor Variant as a Predictor of Response to Androgen-receptor Targeting Agents Used to Treat Castration-refractory Metastatic Prostate Cancer].
metastatic CRPC
(35 times)
(17 times)
CRPC (33 times)
AR (14 times)
ADT (6 times)
2012 Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness.
metastatic castration-resistant PCa
(27 times)
(12 times)
PCa (20 times)
OS (6 times)
PC (6 times)
2012 Current vaccination strategies for prostate cancer.
metastatic prostate cancer
(9 times)
(6 times)
OS (2 times)
PFS (2 times)
PSA (2 times)
2010 Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.
mechanism to anti-AR therapy in castration-resistant prostate cancer
(1 time)
Molecular Biology
(1 time)
AR (1 time)
AR-Vs (1 time)
LBD (1 time)
2017 Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain.
men recently told their castration-resistant prostate cancer has metastasized
(1 time)
Health Services
(1 time)
PSA (1 time)
PSP (1 time)
US (1 time)
2019 Understanding symptomatic experience, impact, and emotional response in recently diagnosed metastatic castration-resistant prostate cancer: a qualitative study.
metastases due to CRPC
(1 time)
(1 time)
EBRT (1 time)
2013 A prospective randomized trial: a comparison of the analgesic effect and toxicity of 153Sm radioisotope treatment in monotherapy and combined therapy including local external beam radiotherapy (EBRT) among metastatic castrate resistance prostate cancer (mCRPC) patients with painful bone metastases.
metastastic Castration Naive Prostate Cancer
(1 time)
(1 time)
ADT (1 time)
mCNPC (1 time)
mPC (1 time)
2019 [Treatment situation in metastastic Castration Naive Prostate Cancer (mCRPC) and the implications on clinical routine].
metastatic cancer types: castration resistant prostate cancer
(1 time)
(1 time)
CAM (1 time)
CTCs (1 time)
EGFR (1 time)
2016 An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer.
10  metastatic disease and eventually castration-resistant prostate cancer
(1 time)
(1 time)
PARP (1 time)
2016 Sequencing Treatment for Castration-Resistant Prostate Cancer.
11  metastatic, castration-sensitive and castration-resistant prostate cancer
(1 time)
AA (1 time)
2018 Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients.
12  symptomatic castration-resistant prostate cancer with bone metastases
(1 time)
(1 time)
ALSYMPCA (1 time)
2018 Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancer.